Cite Filings / RARE / 0001193125-20-287986
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13D

Beneficial Ownership Report

Ultragenyx Pharmaceutical Inc. · Filed 2020-11-06 · Acc 0001193125-20-287986

Documents 1

  • SC 13D Beneficial Ownership Report , d70692dsc13d.htm

Around this filing

  • 2020-11-06 SC 13D Beneficial Ownership Report
  • 2020-11-04 4 President & CEO sold 30,000 shares at $96.82 ($2,904,600)
  • 2020-11-02 4 EVP and General Counsel sold 9,903 shares at $100.12 ($991,488)
  • 2020-11-02 8-K Material agreement
  • 2020-10-30 4 EVP and General Counsel sold 97 shares at $100.00 ($9,700)
  • 2020-10-30 3 Initial Statement of Ownership
  • 2019-06-26 SC 13D Beneficial Ownership Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading d70692dsc13d.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…